Dr. David A Potter M.D.
Hematologist-Oncologist | Hematology & Oncology
420 Delaware St Se Mmc 480 Minneapolis MN, 55455About
Dr. David Potter, MD practices medicine at Minneapolis, Minnesota and specializes in hematology & oncology. Dr. Potter received his medical degree from Johns Hopkins University School Of Medicine and ...
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Calpain regulates enterocyte brush border actin assembly and pathogenic Escherichia coli-mediated effacement.
- TransMiner: mining transitive associations among biological objects from text.
- HPV16 E5 protein disrupts the c-Cbl-EGFR interaction and EGFR ubiquitination in human foreskin keratinocytes.
- Effects of HIV protease inhibitor ritonavir on Akt-regulated cell proliferation in breast cancer.
- Oncology outpatient and provider responses to a computerized symptom assessment system.
- Anastrozole Use in Early Stage Breast Cancer of Post-Menopausal Women.
- Prediction of postoperative recurrence-free survival in non-small cell lung cancer by using an internationally validated gene expression model.
- The human immunodeficiency virus protease inhibitor ritonavir inhibits lung cancer cells, in part, by inhibition of survivin.
- CYP3A4 mediates growth of estrogen receptor-positive breast cancer cells in part by inducing nuclear translocation of phospho-Stat3 through biosynthesis of (±)-14,15-epoxyeicosatrienoic acid (EET).
- Should diabetic women with breast cancer have their own intervention studies?
- CYP1A1 regulates breast cancer proliferation and survival.
- Metformin Treatment for the Prevention and/or Treatment of Breast/Mammary Tumorigenesis.
- Etirinotecan pegol (NKTR-102) versus treatment of physician's choice in women with advanced breast cancer previously treated with an anthracycline, a taxane, and capecitabine (BEACON): a randomised, open-label, multicentre, phase 3 trial.
- Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial.
- Erratum to: Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial.
Dr. David A Potter M.D.'s Practice location
Dr. David A Potter M.D.'s reviews
Write ReviewRecommended Articles
- Roles of the National Coalition for Cancer Survivorship
The National Coalition for Cancer Survivorship (NCCS) is a nonprofit, cancer advocacy organization that is located just outside of Washington D.C. To date, it is the oldest survivor-led cancer advocacy organization in the United States.The NCCS represents millions of Americans who share a common...
- Schools Join the Fight Against Lymphoma and Blood Cancers
Students at St. Paul Catholic School in Weirton, West Virginia have made their mark in the battle against cancer. By participating in a Student Series program hosted by the Leukemia and Lymphoma Society, students were able to raise $2,006.93 and donate the proceeds to discovering a cure for...
- Lymphoma: The Importance of a Support System & Communication
Regardless of what’s being said, communication is something that many people struggle with in their personal relationships. Communication requires self-awareness, listening skills, and the ability to empathize and convey thoughts and feelings accurately. When people are diagnosed with chronic...
- Survey Shows Lack of Blood Cancer Knowledge Among Americans
If anyone is asked to describe what cancer is, chances are they’ll be able to provide at least a rough definition of the disease. Generally speaking, cancer is the name for the rapid and uncontrollable development of cells in a certain part of the body. In addition to holding a general awareness...
- How to Show Social Support for Lymphoma
A cancer diagnosis can shake an individual’s world, and not just the physical aspects of their world, but all corners of it. Although cancer attacks the body, it necessarily also affects a person’s mental and emotional state, and it can have an impact on other people close to the affected...
- The Promising Future of Gene Therapy and Lymphoma
Non-Hodgkin lymphoma affects over 700,000 people in America alone. Though current treatments are moderately effective, especially for aggressive forms of the disease, more can be done to help people impacted by NHL. Researchers are doing just that by working to develop new, innovative treatment for...
Nearby Providers
- Dr. Gregory M Vercellotti MD424 Harvard Street Se Minneapolis MN 55455
- Dr. John F Schwerkoske M.D.6025 Lake Rd Saint Paul MN 55125
- Dr. Mukta Arora M.B., B.S.516 Delaware Street Se Minneapolis MN 55455
- Dr. Nelli Bejanyan M.D.516 DELAWARE ST SE MINNEAPOLIS MN 55455
- Dr. Veronika Bachanova MD516 Delaware St Se Minneapolis MN 55455
- Dr. Naomi Fujioka MD500 Harvard St Se Minneapolis MN 55455